Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
191 participants
INTERVENTIONAL
2006-03-09
2022-08-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Our specific aims in the proposed study are to:
* Conduct an initial evaluation of whether participation in the yoga program improves patients' fatigue and sleep disturbances. Fatigue and sleep will be assessed with self-report measures and the use of actigraphy for a more objective measure of sleep quality.
* Secondary end points will include examining QOL, mental health and objective physiological outcomes (blood samples for immune measures, saliva samples for cortisol levels, and heart rate variability).
* Exploratory analyses will examine some plausible mediators of the yoga program including cognitive processing, spirituality, and finding meaning in the cancer experience.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Role of Exercise in Breast Cancer Patient Undergoing Treatment
NCT05009849
Yoga Study in Breast Cancer Patients
NCT00476203
Yoga for Breast Cancer
NCT01985945
Yoga on QOL Physiological Distress&Fatigue, on Patients Affected by Breast Cancer in Adjuvant Radiotherapy
NCT04775290
Randomized Controlled Trial Evaluating the Role of Exercise in Women Undergoing Treatment for Breast Cancer
NCT02161900
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
After your first visit to M. D. Anderson or after a researcher has visited you at home, you will be randomly assigned (as in the toss of a coin) to one of 3 groups.
Participants in the first group will take part in a yoga program. If you are assigned to the yoga group, you will take part in 3 sessions of yoga each week for 6 weeks. You may take part in the yoga sessions any 3 days of the week. Each yoga session will last around 60 minutes. During the yoga sessions, you will also be asked to do breathing exercises and to perform different movements and meditation. None of the movements are difficult. You will be able to follow this program at your own pace.
Participants in the second group will take part in a stretching program. If you are assigned to the stretching group, you will take part in 3 sessions of stretching each week for 6 weeks. You may take part in the stretching sessions any 3 days of the week. Each stretching session will last around 60 minutes. During these stretching sessions you will be asked to do simple stretching exercises. None of the movements are difficult. You will be able to follow this program at your own pace.
Beginning with the second week, participants in the first and second groups will be asked to complete a brief questionnaire, about the yoga or stretching program, before the first class each week. The questionnaire will take about 1 to 2 minutes to complete. You will also have an ECG and your breathing rate will be measured before and after one of the classes during the third or fourth week and again during the last week. Each stretching and yoga session will be audio and video taped for the purpose of quality control.
Participants in the third group will not take part in the yoga or stretching program during this study. However, if you are assigned to this group, you will be given the option of participating in the yoga or stretching program after the study has ended. This will be after you have finished your last assessment.
All participants will complete a brief questionnaire during the middle of radiotherapy. The questionnaire will evaluate your treatment-related symptoms and will take about 15 minutes to complete.
During the last week of radiotherapy, and at 1, 3, and 6 months after the end of radiation treatment, all participants will be asked to fill out a packet of questionnaires (similar to those taken at the first visit). It should take about 45 minutes to complete all of the questionnaires. If it is not convenient for you to come to M. D. Anderson, a researcher can visit you at home to help with the questionnaires. You will then be asked to complete another daily sleep diary for another 7 days. During this time, you will wear an actigraph watch 24 hours a day for 7 days a week to collect the same data as before. During this time, you will have an ECG and your breathing rate will be measured.
All participants will be asked to refrain from participating in any other yoga classes for the duration of the study.
Your participation in this study will be over after your 6-month assessment.
This is an investigational study. Up to 180 patients will take part in this study. All will be enrolled at M. D. Anderson.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1 Yoga Program
3 sessions of yoga each week for 6 weeks. Questionnaire evaluating treatment-related symptoms during the middle of radiotherapy.
Yoga Group
3 sessions of yoga each week for 6 weeks.
Questionnaire
Questionnaire evaluating treatment-related symptoms during the middle of radiotherapy.
Group 2 Stretching Program
3 sessions of stretching each week for 6 weeks. Questionnaire evaluating treatment-related symptoms during the middle of radiotherapy.
Stretching Control Group
3 sessions of stretching each week for 6 weeks
Questionnaire
Questionnaire evaluating treatment-related symptoms during the middle of radiotherapy.
Group 3 Waitlist Control Group
Option of participating in the yoga or stretching program after the study has ended. Questionnaire evaluating treatment-related symptoms during the middle of radiotherapy.
Waitlist Control Group
Option of participating in the yoga or stretching program after the study has ended.
Questionnaire
Questionnaire evaluating treatment-related symptoms during the middle of radiotherapy.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Yoga Group
3 sessions of yoga each week for 6 weeks.
Stretching Control Group
3 sessions of stretching each week for 6 weeks
Waitlist Control Group
Option of participating in the yoga or stretching program after the study has ended.
Questionnaire
Questionnaire evaluating treatment-related symptoms during the middle of radiotherapy.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. The participants will need to be 18 years of age or older.
3. Patients should be able to read, write, and speak English or Spanish.
Exclusion Criteria
2. Patients with metastatic disease of the bone will be excluded to avoid any bone fractures that may result from yoga movements.
3. Patients with active/non-canalized deep vein thrombosis will be excluded from the study.
4. Patients who have not undergone any surgical treatment for their cancer will be excluded to ensure a more homogeneous sample.
5. Patients with extreme mobility issues (e.g., unable to get in and out of a chair unassisted) will be excluded.
6. Patients who have practiced yoga or taken yoga classes in the year prior to diagnosis will be excluded.
7. Patients diagnosed with lymphedema at baseline will be excluded.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institutes of Health (NIH)
NIH
National Cancer Institute (NCI)
NIH
M.D. Anderson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lorenzo Cohen, PhD
Role: PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
University of Texas MD Anderson Cancer Center Website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CA102385
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
NCI-2010-00743
Identifier Type: REGISTRY
Identifier Source: secondary_id
2005-0522
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.